CTT Pharmaceutical Holdings, Inc.'s Form 4/A amendment
AmendedCTT Pharmaceutical Holdings, Inc. (CTTH) · filed Sep 29, 2026
- Accession no.
- 0001035422-26-000015
- Filed
- Sep 29, 2026, 10:22 AM ET
- Trade date
- Sep 22, 2026
- Filing delay
- 7 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Sep 22, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $454.5. It was filed 7 days after the trade.
This amendment replaces 0001035422-26-000013 (filed Sep 22, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CTT Pharmaceutical Holdings, Inc.CIK 0001035422 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | CTTH | PPurchaseAcquired | +10,100 | $0.045 | +$454.5 | 9,424,556 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
The shares held for 9/22/26 were incorrect. The correct number is 9,424,556.